Seres Therapeutics (1S90.F) Q1 2025 Earnings

13MarConfirmed
Q1 2025
-3.62
-2.97
-2.31
-1.66

Details

Expected EPS
-3.62156167135
Actual EPS
-1.658682
Surprise EPS
1.96
Surprise Percent
+54.2%

Description

Seres Therapeutics (1S90.F) has reported earnings of -1.658682 per share for Q1 2025.

0 Comments

Share your thoughts